商务合作
动脉网APP
可切换为仅中文
Combining Expanded Real-World Data Network with Briya AIRE™ Research Engine Will Accelerate Clinical Trials and Drive Personalized Medicine
结合扩展的现实世界数据网络与Briya AIRE™研究引擎,将加速临床试验并推动个性化医疗的发展。
NEW YORK
纽约
,
,
April 14, 2026
2026年4月14日
/PRNewswire/ --
/PRNewswire/ --
Briya
布里亚
, the health AI technology company redefining healthcare research, today announced its global data network has expanded to cover over 120 million patient records. By unifying this massive real-world data (RWD) repository with the
,这家重新定义医疗保健研究的健康人工智能技术公司今天宣布,其全球数据网络已经扩展到覆盖超过1.2亿份患者记录。通过将这个庞大的真实世界数据(RWD)存储库与
Briya AIRE™
布里亚人工智能™
research engine, Briya is delivering a scalable solution to address the industry's need for diverse, high-fidelity patient representation to advance medical innovation and personalized medicine.
研究引擎,Briya 正在提供一个可扩展的解决方案,以满足行业对多样化、高保真患者表现的需求,推动医学创新和个性化医疗的发展。
'Reaching this milestone is a critical step forward for Briya and provides a vital resource for the entire healthcare and life sciences ecosystem by increasing access to more representative real-world data,' said David Lazerson, Co-founder and CEO of Briya. 'Clinical research has traditionally been constrained by fragmented and overly homogenous datasets that do not capture the full complexity of human health.
“达成这一里程碑是Briya向前迈出的关键一步,通过增加对更具代表性的真实世界数据的访问,为整个医疗保健和生命科学生态系统提供了重要资源,”Briya联合创始人兼首席执行官David Lazerson表示。“临床研究传统上受到碎片化和过于同质化数据集的限制,无法充分捕捉人类健康的全部复杂性。”
By bringing high-quality, multimodal data from diverse patient populations, we're helping researchers and pharmaceutical developers to conduct studies that are truly representative, making clinical trials faster, more precise and truly equitable.'.
通过提供来自不同患者群体的高质量、多模态数据,我们正在帮助研究人员和制药开发者开展真正具有代表性的研究,使临床试验更快速、更精确且真正公平。
Building on a strong global data footprint – including 50 million patient records across the United States and European Union, in addition to robust datasets in Asia and the Middle East – Briya has expanded its network to Latin America and the United Kingdom. The Latin American expansion provides high population diversity and genetic variety essential for more inclusive research and rapid trial matching.
基于强大的全球数据基础——包括美国和欧盟的5000万患者记录,以及亚洲和中东的丰富数据集——Briya已将其网络扩展到拉丁美洲和英国。拉丁美洲的扩展提供了高人口多样性和遗传多样性,这对更具包容性的研究和快速试验匹配至关重要。
The addition of over 3 million UK patient records delivers high-value longitudinal data from a universal healthcare model that captures comprehensive patient journeys across primary and secondary care. Access to this data will enable researchers to track long-term treatment outcomes, generate real-world evidence and optimize identification of eligible trial candidates..
超过 300 万英国患者记录的加入提供了一个普遍医疗保健模式的高价值纵向数据,该数据全面捕捉了初级和二级医疗中的患者旅程。获取这些数据将使研究人员能够追踪长期治疗结果、生成真实世界证据并优化合格试验候选人的识别。
'Briya's expansive data network represents a vital step forward for Tanner Health and our patient population across nine counties in west Georgia and east Alabama,' said Steve West, Managing Director of Tanner Health System. 'The ability to securely access and share high-quality, multimodal medical data means our patient populations are actively represented in the future of global medicine, while Briya's secure infrastructure and advanced capabilities offer the opportunity to collaborate with global researchers.'.
“Briya庞大的数据网络代表了Tanner Health及其覆盖佐治亚州西部和阿拉巴马州东部九个县的患者群体向前迈出的重要一步,”Tanner Health System董事总经理Steve West表示。“能够安全访问和共享高质量、多模式的医疗数据,意味着我们的患者群体在全球医学的未来中得到了积极体现,而Briya的安全基础设施和先进功能为我们提供了与全球研究人员合作的机会。”
Integrated with the
集成与
Briya AIRE
布里娅人工智能研究与工程
research engine, Briya's global network enables medical and biopharma researchers to access rich datasets providing comprehensive patient journeys by tapping directly into electronic health records, lab tests, images and other structured sources, with the ability to access unstructured formats using natural language processing (NLP) data extraction.
研究引擎,Briya的全球网络使医疗和生物制药研究人员能够访问丰富的数据集,通过直接获取电子健康记录、实验室测试、图像和其他结构化来源,提供全面的患者旅程,并能够使用自然语言处理(NLP)数据提取访问非结构化格式。
Users can access datasets curated in real-time and tailored to their specific needs, including a range of modalities, full treatment journeys, genetics and biomarkers. All data is fully anonymized, in compliance with international privacy laws..
用户可以访问实时策划并根据其特定需求定制的数据集,这些数据集包括多种模式、完整的治疗过程、遗传学和生物标志物。所有数据均完全匿名化,并符合国际隐私法律。
For more information or to request a demo, please visit:
如需更多信息或申请演示,请访问:
Briya AIRE Info Request
布里亚AIRE信息请求
About Briya
关于Briya
Briya is a healthcare technology company dedicated to supporting vital medical and biopharma research and innovation with AI and data. Briya AIRE™, the first AI research engine built specifically for clinical and biomedical research, serves as an AI assistant across academia and the pharmaceutical industry.
Briya是一家致力于通过人工智能和数据支持重要医疗和生物制药研究与创新的医疗技术公司。Briya AIRE™是首个专为临床和生物医学研究构建的AI研究引擎,作为学术界和制药行业的AI助手。
It can collect and analyze complex clinical data, generating insights that can be used to design cohorts, validate endpoints and meet key development milestones. With full anonymization and a federated data approach, Briya accelerates the path to discoveries while maintaining the highest standards of security, compliance, and trust..
它可以收集和分析复杂的临床数据,生成可用于设计队列、验证终点和满足关键开发里程碑的见解。通过完全匿名化和联合数据方法,Briya在加速发现路径的同时,保持了最高标准的安全性、合规性和信任度。
For more information, follow us on
欲了解更多信息,请关注我们
领英
and
和
X
X
, or visit
,或者访问
https://briya.com
https://briya.com
.
。
Media Contact:
媒体联系人:
FINN Partners for Briya
芬恩伙伴为布里亚
Danny Sudwarts
丹尼·苏德沃茨
[email protected]
电子邮件地址
SOURCE Briya
源 Briya
21
21
%
%
more press release views with
更多新闻稿浏览量与
Request a Demo
请求演示